Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 30;86(3):1297-1303.
doi: 10.1097/MS9.0000000000001772. eCollection 2024 Mar.

Safety and efficacy of extended thrombophilia screening directed venous thromboembolic events (VTE) prophylaxis in live liver donors: do we really need extended thrombophilia screening routinely?

Abdul Wahab Dogar  1 , Azhar Hussain  1 , Kaleem Ullah  1 , Shams-Ud-Din  1 , Abdul Ghaffar  1 , Khabab Abbasher Hussien Mohamed Ahmed  2 , Muhammad Junaid Tahir  3
Affiliations

Safety and efficacy of extended thrombophilia screening directed venous thromboembolic events (VTE) prophylaxis in live liver donors: do we really need extended thrombophilia screening routinely?

Abdul Wahab Dogar et al. Ann Med Surg (Lond). .

Abstract

Background and aims: The study aimed to determine the prevalence of hereditary thrombophilia, and stratify its severity among live liver donors in Pakistan. Also, the authors evaluated the safety and efficacy of thrombophilia profile testing directed venous thromboembolic events (VTE) prophylaxis while balancing bleeding risk and the need for routine thrombophilia testing before live liver donation among living donor candidates.

Materials and methods: Protein S (PS), protein C (PC), anti-thrombin (AT) III, and anti-phospholipid antibody panel (APLA) levels were measured in 567 potential donor candidates. Donors were divided into normal, borderline and high-risk groups based on Caprini score. The safety endpoints were VTE occurrence, bleeding complications or mortality.

Results: Among 567 donors, 21 (3.7%) were deficient in protein C, and 14 (2.5%) were deficient in anti-thrombin-III. IgM and IgG. Anti-phospholipids antibodies were positive in 2/567 (0.4%) and 2/567 (0.4%), respectively. IgM and IgG lupus anticoagulant antibodies were positive in 3/567 (0.5%) and 3/567 (0.5%), respectively. VTE events, bleeding complications and postoperative living donors liver transplantation-related complications were comparable among the three donor groups (P>0.05). One donor in the normal donor group developed pulmonary embolism, but none of the donors in either borderline or high-risk group developed VTE. The mean length of ICU and total hospital stay were comparable. No donor mortality was observed in all donor groups.

Conclusions: Due to thrombophilia testing directed VTE prophylaxis, VTE events were comparable in normal, borderline and high-risk thrombophilia donor groups, but more evaluations are required to determine the lower safe levels for various thrombophilia parameters including PC, PS and AT-III before surgery among living donor candidates.

Keywords: live liver donors; living donors liver transplantation (LDLT); thrombophilia screening; venous thromboembolic events.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest of any author.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Similar articles

See all similar articles

References

    1. Ma L, Lu Q, Luo Y. Vascular complications after adult living donor liver transplantation: evaluation with ultrasonography. World J Gastroenterol 2016;22:1617–1626. - PMC - PubMed
    1. Rather SA, Nayeem MA, Agarwal S, et al. . Vascular complications in living donor liver transplantation at a high‐volume center: Evolving protocols and trends observed over 10 years. Liver Transplantat 2017;23:457–464. - PubMed
    1. Kamei H, Onishi Y, Kurata N, et al. . Donor selection and prophylactic strategy for venous thromboembolic events in living donors of liver transplantation based on results of thrombophilia screening tests. Ann Transplant 2017;22:409–416. - PMC - PubMed
    1. Dogar AW, Uddin S, Ghaffar A, et al. . Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learned. BMJ Open Gastroenterol 2021;8:e000723. - PMC - PubMed
    1. Dogar AW, Ullah K, Ghaffar A, et al. . Safety of glucose-6 phosphate dehydrogenase deficient donors in living right lobe liver donation. Clin Transplant 2022;36:e14627. - PubMed